Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma

Oral Oncology

Volumn 46, Issue 7, 2010, Pages 536-542

  Waseem, Ahmad ^a   Ali, Muhammad ^a   Odell, Edward W ^b   Fortune, Farida ^a   Teh, Muy Teck ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bioinformatics; CEP55; Diagnostic biomarkers; Digital densitometry; Early detection; FOXM1; Head and neck; HELLS; HNSCC; Immunohistochemistry; LSH; Microarray; Oncogene; Oral cancer; Oral carcinoma; PASG; qPCR; Real time quantitative PCR; SMARCA6

Indexed keywords

MESSENGER RNA;

ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DYSPLASIA; GENE TARGETING; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LYMPH NODE METASTASIS; MICROARRAY ANALYSIS; MOUTH MUCOSA; ONCOGENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DNA HELICASES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; MOUTH MUCOSA; NUCLEAR PROTEINS; PILOT PROJECTS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77953357848     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.03.022     Document Type: Article

References (49)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 2 (2005) 74-108
2. La Vecchia C., Lucchini F., Negri E., and Levi F. Trends in oral cancer mortality in Europe. Oral Oncol 40 4 (2004) 433-439
3. Teh M.T., Wong S.T., Neill G.W., Ghali L.R., Philpott M.P., and Quinn A.G. FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res 62 16 (2002) 4773-4780
4. Wierstra I., and Alves J. FOXM1, a typical proliferation-associated transcription factor. Biol Chem 388 12 (2007) 1257-1274
5. Myatt S.S., and Lam E.W. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 7 11 (2007) 847-859
6. Laoukili J., Stahl M., and Medema R.H. FoxM1: at the crossroads of ageing and cancer. Biochim Biophys Acta 1775 1 (2007) 92-102
7. Gemenetzidis E., Bose A., Riaz A.M., Chaplin T., Young B.D., Ali M., et al. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. PLoS ONE 4 3 (2009) e4849
8. Luscher-Firzlaff J.M., Westendorf J.M., Zwicker J., Burkhardt H., Henriksson M., et al. Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation. Oncogene 18 41 (1999) 5620-5630
9. Wiest T., Schwarz E., Enders C., Flechtenmacher C., and Bosch F.X. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 21 10 (2002) 1510-1517
10. Ha P.K., Pai S.I., Westra W.H., Gillison M.L., Tong B.C., Sidransky D., et al. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res 8 5 (2002) 1203-1209
11. Braakhuis B.J., Snijders P.J., Keune W.J., Meijer C.J., Ruijter-Schippers H.J., Leemans C.R., et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 96 13 (2004) 998-1006
12. Fabbro M., Zhou B.B., Takahashi M., Sarcevic B., Lal P., Graham M.E., et al. Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis. Dev Cell 9 4 (2005) 477-488
13. Martinez-Garay I., Rustom A., Gerdes H.H., and Kutsche K. The novel centrosomal associated protein CEP55 is present in the spindle midzone and the midbody. Genomics 87 2 (2006) 243-253
14. Zhao W.M., Seki A., and Fang G. Cep55, a microtubule-bundling protein, associates with centralspindlin to control the midbody integrity and cell abscission during cytokinesis. Mol Biol Cell 17 9 (2006) 3881-3896
15. Geiman T.M., Durum S.K., and Muegge K. Characterization of gene expression, genomic structure, and chromosomal localization of Hells (Lsh). Genomics 54 3 (1998) 477-483
16. Geiman T.M., and Muegge K. Lsh, an SNF2/helicase family member, is required for proliferation of mature T lymphocytes. Proc Natl Acad Sci USA 97 9 (2000) 4772-4777
17. Assou S., Le Carrour T., Tondeur S., Strom S., Gabelle A., Marty S., et al. A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells 25 4 (2007) 961-973
18. McGraw S., Vigneault C., and Sirard M.A. Temporal expression of factors involved in chromatin remodeling and in gene regulation during early bovine in vitro embryo development. Reproduction 133 3 (2007) 597-608
19. Ghali L., Wong S.T., Green J., Tidman N., and Quinn A.G. Gli1 protein is expressed in basal cell carcinomas, outer root sheath keratinocytes and a subpopulation of mesenchymal cells in normal human skin. J Invest Dermatol 113 4 (1999) 595-599
20. Teh M.T., Blaydon D., Ghali L.R., Edmunds S., Pantazi E., Barnes M.R., et al. Role for WNT16B in human epidermal keratinocyte proliferation and differentiation. J Cell Sci 120 2 (2007) 330-339
21. Lalli A., Tilakaratne W.M., Ariyawardana A., Fitchett C., Leigh I.M., Hagi-Pavli E., et al. An altered keratinocyte phenotype in oral submucous fibrosis: correlation of keratin K17 expression with disease severity. J Oral Pathol Med 37 4 (2008) 211-220
22. Rheinwald J.G., Hahn W.C., Ramsey M.R., Wu J.Y., Guo Z., Tsao H., et al. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol Cell Biol 22 14 (2002) 5157-5172
23. Dickson M.A., Hahn W.C., Ino Y., Ronfard V., Wu J.Y., Weinberg R.A., et al. Human keratinocytes that express hTERT and also bypass a p16(INK4a) - enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 20 4 (2000) 1436-1447
24. Chang S.E., Foster S., Betts D., and Marnock W.E. DOK, a cell line established from human dysplastic oral mucosa, shows a partially transformed non-malignant phenotype. Int J Cancer 52 6 (1992) 896-902
25. Rheinwald J.G., and Beckett M.A. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 41 5 (1981) 1657-1663
26. Reiss M., Pitman S.W., and Sartorelli A.C. Modulation of the terminal differentiation of human squamous carcinoma cells in vitro by all-trans-retinoic acid. J Natl Cancer Inst 74 5 (1985) 1015-1023
27. Locke M., Heywood M., Fawell S., and Mackenzie I.C. Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res 65 19 (2005) 8944-8950
28. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55 4 (2009) 611-622
29. Toruner G.A., Ulger C., Alkan M., Galante A.T., Rinaggio J., Wilk R., et al. Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. Cancer Genet Cytogenet 154 1 (2004) 27-35
30. Myatt S.S., and Lam E.W. Targeting FOXM1. Nat Rev Cancer 8 3 (2008) 242
31. Ye H., Kelly T.F., Samadani U., Lim L., Rubio S., Overdier D.G., et al. Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues. Mol Cell Biol 17 3 (1997) 1626-1641
32. Chen C.H., Lu P.J., Chen Y.C., Fu S.L., Wu K.J., Tsou A.P., et al. FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway. Oncogene 26 29 (2007) 4272-4283
33. Chen C.H., Lai J.M., Chou T.Y., Chen C.Y., Su L.J., Lee Y.C., et al. VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3K/AKT pathway. PLoS ONE 4 4 (2009) e5052
34. Martin K.J., Patrick D.R., Bissell M.J., and Fournier M.V. Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets. PLoS ONE 3 8 (2008) e2994
35. Carter S.L., Eklund A.C., Kohane I.S., Harris L.N., and Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 38 9 (2006) 1043-1048
36. Inoda S., Hirohashi Y., Torigoe T., Nakatsugawa M., Kiriyama K., Nakazawa E., et al. Cep55/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma. J Immunother 32 5 (2009) 474-485
37. Lee D.W., Zhang K., Ning Z.Q., Raabe E.H., Tintner S., Wieland R., et al. Proliferation-associated SNF2-like gene (PASG): a SNF2 family member altered in leukemia. Cancer Res 60 13 (2000) 3612-3622
38. Raabe E.H., Abdurrahman L., Behbehani G., and Arceci R.J. An SNF2 factor involved in mammalian development and cellular proliferation. Dev Dyn 221 1 (2001) 92-105
39. Dennis K., Fan T., Geiman T., Yan Q., and Muegge K. Lsh, a member of the SNF2 family, is required for genome-wide methylation. Genes Dev 15 22 (2001) 2940-2944
40. Yan Q., Cho E., Lockett S., and Muegge K. Association of Lsh, a regulator of DNA methylation, with pericentromeric heterochromatin is dependent on intact heterochromatin. Mol Cell Biol 23 23 (2003) 8416-8428
41. Yan Q., Huang J., Fan T., Zhu H., and Muegge K. Lsh, a modulator of CpG methylation, is crucial for normal histone methylation. EMBO J 22 19 (2003) 5154-5162
42. Myant K., and Stancheva I. LSH cooperates with DNA methyltransferases to repress transcription. Mol Cell Biol 28 1 (2008) 215-226
43. Geiman T.M., Tessarollo L., Anver M.R., Kopp J.B., Ward J.M., and Muegge K. Lsh, a SNF2 family member, is required for normal murine development. Biochim Biophys Acta 1526 2 (2001) 211-220
44. Sun L.Q., Lee D.W., Zhang Q., Xiao W., Raabe E.H., Meeker A., et al. Growth retardation and premature aging phenotypes in mice with disruption of the SNF2-like gene, PASG. Genes Dev 18 9 (2004) 1035-1046
45. Zhou R., Han L., Li G., and Tong T. Senescence delay and repression of p16INK4a by Lsh via recruitment of histone deacetylases in human diploid fibroblasts. Nucleic Acids Res 37 15 (2009) 5183-5196
46. Yano M., Ouchida M., Shigematsu H., Tanaka N., Ichimura K., Kobayashi K., et al. Tumor-specific exon creation of the HELLS/SMARCA6 gene in non-small cell lung cancer. Int J Cancer 112 1 (2004) 8-13
47. Einbond L.S., Su T., Wu H.A., Friedman R., Wang X., Jiang B., et al. Gene expression analysis of the mechanisms whereby black cohosh inhibits human breast cancer cell growth. Anticancer Res 27 2 (2007) 697-712
48. Ryu B., Kim D.S., Deluca A.M., and Alani R.M. Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. PLoS ONE 2 7 (2007) e594
49. Sen G.L., Reuter J.A., Webster D.E., Zhu L., and Khavari P.A. DNMT1 maintains progenitor function in self-renewing somatic tissue. Nature 463 7280 (2010) 563-567